Paper39482199
Advances in triterpene drug discovery.
Goddard ZR and 2 others. Trends Pharmacol Sci, 2024. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Advances in triterpene drug discovery. Papers, record 39482199. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39482199
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Triterpenes | Major topic |
| Drug Discovery | Major topic |
| Humans | |
| Animals | |
| Biological Products |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866665 | Diverse oxidosqualene cyclases for triterpenoid biosynthesis. | Synth Syst Biotechnol | 2027 | https://conductscience.org/library/papers/42866665 | PubMed |
| 42156616 | A comprehensive review on the chemical composition, pharmacological effects and quality evaluation of Gentiana straminea Maxim. | J Nat Med | 2026 | https://conductscience.org/library/papers/42156616 | PubMed |
| 41976251 | Cirsium arvense and Cirsium vulgare: Comparative Ethnopharmacology, Phytochemistry and Pharmacological Review. | Molecules | 2026 | https://conductscience.org/library/papers/41976251 | PubMed |
| 41859725 | Yeast species resource exploration and application in cell factories. | Synth Syst Biotechnol | 2026 | https://conductscience.org/library/papers/41859725 | PubMed |
| 41858113 | Engineering Salvia miltiorrhiza hairy roots as a scalable platform for high-yield production of paclitaxel and ginsenoside precursors. | Plant Commun | 2026 | https://conductscience.org/library/papers/41858113 | PubMed |
| 41359225 | Harnessing transcriptomics for discovery of natural products to overcome acquired cancer resistance. | Arch Pharm Res | 2026 | https://conductscience.org/library/papers/41359225 | PubMed |
| 41322296 | Triterpenes in breast cancer: a systematic review of preclinical evidence in rodents. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41322296 | PubMed |
| 40579143 | [Ecliptasaponin A ameliorates DSS-induced colitis in mice by suppressing M1 macrophage polarization via inhibiting the JAK2/STAT3 pathway]. | Nan Fang Yi Ke Da Xue Xue Bao | 2025 | https://conductscience.org/library/papers/40579143 | PubMed |
| 40445525 | Yinling Qushi Granule as a therapeutic agent for metabolic syndrome: pharmacological, molecular targets, and pharmacokinetic insights. | Adv Biotechnol (Singap) | 2025 | https://conductscience.org/library/papers/40445525 | PubMed |
| 40430532 | A Direct Relationship Between 'Blood Stasis' and Fibrinaloid Microclots in Chronic, Inflammatory, and Vascular Diseases, and Some Traditional Natural Products Approaches to Treatment. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430532 | PubMed |
| 40011284 | Salicylic acid-induced upregulation of AtAACT and AtMVD expression enhances triterpene biosynthesis in Athelia termitophila. | World J Microbiol Biotechnol | 2025 | https://conductscience.org/library/papers/40011284 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39482199
GET https://conductscience.org/api/papers/v1/39482199/authors